Quick Answer
Celularity Inc reported Research And Development Expense of $17.39 million for the year ending 2024.
- Celularity Inc showed a decrease of -42.9% in Research And Development Expense from 2023 to 2024.
- This data is from Celularity Inc's annual report (Form 10-K), filed with the SEC on May 8, 2025.
- XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2020 to 2024), Celularity Inc's Research And Development Expense has declined by 67.0%.
- Historical annual values: Fiscal year 2024: $17.39 million | Fiscal year 2023: $30.47 million | Fiscal year 2022: $78.36 million | Fiscal year 2021: $88.35 million | Fiscal year 2020: $52.71 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: